CoverorDie
September 7, 2026

Squeeze Report — September 7, 2026

Biotech dominates today's squeeze screen, but the setups are mostly pre-paid: crowded options, cheap borrow, and heavy dilution overhangs cap upside across SLS, SRPT, TGTX, and AMLX. The more interesting tension sits in GRRR, where a 40% short interest and rising borrow costs collide with unresolved fraud allegations.

15 ranked2 hot (≥80)15 squeezable (≥73)

Today's top short-squeeze candidates

  1. #1SLDBSolid Biosciences Inc. Common82

    21% of float sold short · 19.6 days to cover · +22% over 20 days · options pricing in the 100th percentile (crowded)

    SI 21%DTC 19.6$10.25+22% 20dHealthcare
  2. #2CHPTChargePoint Holdings, Inc.80

    25% of float sold short · 15.6 days to cover · +59% over 20 days

    SI 25%DTC 15.6$9.89+59% 20dConsumer Cyclical
  3. #3CELCCelcuity Inc. Common Stock80

    35% of float sold short · 13.2 days to cover · +3% over 20 days

    SI 35%DTC 13.2$95.70+3% 20dHealthcare
  4. #4VERAVera Therapeutics, Inc. Class79

    ORIGIN 3 final efficacy in Q3 is the trigger, but sub-0.5% borrow and a $200M ATM mean shorts aren't trapped.

    SI 29%DTC 7.0$35.89+9% 20dHealthcare
  5. #5GRRRGorilla Technology Group Inc.79

    40% short interest and an 11% borrow fee, but Culper fraud claims and negative gross margin make this a high-risk, high-reward brawl.

    SI 40%DTC 5.2$13.79+5% 20dTechnology
  6. #6TGTXTG Therapeutics, Inc. Common S79

    12.6 days to cover and a 40% base rate, but cheap borrow and crowded options pre-pay the move.

    SI 22%DTC 12.6$55.99+13% 20dHealthcare
  7. #7CRKComstock Resources, Inc.79

    31% of float sold short · 13.4 days to cover · +14% over 20 days · options pricing in the 100th percentile (crowded)

    SI 31%DTC 13.4$15.26+14% 20dEnergy
  8. #8AMLXAmylyx Pharmaceuticals, Inc. C78

    The LUCIDITY pop already happened; a $500M offering and 14M new shares dilute what's left of the squeeze.

    SI 16%DTC 7.1$34.10+49% 20dHealthcare
  9. #9CNXCConcentrix Corporation Common77

    23% of float sold short · 10.6 days to cover · +25% over 20 days

    SI 23%DTC 10.6$32.16+25% 20dTechnology
  10. #10DFDVDeFi Development Corp. Common77

    35.9% short interest and insider buying, but a $200M ATM and $210M of debt-like obligations make this fragile.

    SI 36%DTC 9.2$5.87+103% 20dFinancial Services
  11. #11SRPTSarepta Therapeutics, Inc. Com76

    34% 20-day run and 28.6% short interest, but ELEVIDYS safety overhang and 100th-percentile IV suggest fade risk on any good news.

    SI 29%DTC 9.1$22.50+34% 20dHealthcare
  12. #12PEGAPegasystems Inc. Common Stock76

    13% of float sold short · 7.4 days to cover · +14% over 20 days

    SI 13%DTC 7.4$37.36+14% 20dTechnology
  13. #13PRGOPERRIGO COMPANY PLC76

    The Aug 5 earnings pop already happened; a $3.3B debt load and 2027 price-fixing trial cap further upside.

    SI 16%DTC 6.9$14.92+16% 20dHealthcare
  14. #14BHVNBiohaven Ltd.75

    14% of float sold short · 10.3 days to cover · +7% over 20 days

    SI 14%DTC 10.3$15.69+7% 20dHealthcare
  15. #15VIRVir Biotechnology, Inc. Common75

    13.6 days to cover and a 29% 20-day run, but no hard catalyst until Q4 ECLIPSE 1 data leaves shorts unpressed.

    SI 15%DTC 13.6$11.39+29% 20dHealthcare

See the full ranked board

This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.

Open the live squeeze board →